Ignite Creation Date:
2025-12-25 @ 3:24 AM
Ignite Modification Date:
2026-01-09 @ 11:06 PM
Study NCT ID:
NCT05987605
Status:
TERMINATED
Last Update Posted:
2025-02-19
First Post:
2023-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/II Clinical Study of 1A46 Drug Substance
Sponsor:
BioRay Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2023-07-10
First Submit QC Date:
None
Study First Post Date:
2023-08-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-17
Last Update Post Date:
2025-02-19
Last Update Post Date Type:
ACTUAL